ONKURE THERAPEUTICS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
ONKURE THERAPEUTICS, INC. (OKUR) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$78.13 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2024-03-28
- ONKURE THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$78.13M.
- ONKURE THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$51.99M.
- ONKURE THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2021 was -$39.72M.
- ONKURE THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2020 was -$21.29M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2023-12-31 | -$78.13M 10-K · filed 2024-03-28 |
| 2022-12-31 | -$51.99M 10-K · filed 2024-03-28 |
| 2021-12-31 | -$39.72M 10-K · filed 2023-03-27 |
| 2020-12-31 | -$21.29M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |